AsiaTechDaily – Asia's Leading Tech and Startup Media Platform
Singapore-based venture capital firm Jungle Ventures has announced its merger with HealthXCapital, an early-stage VC firm specializing in healthcare investments. The partnership is set to infuse Jungle Ventures with the expertise of the HealthXCapital team, enabling the firm to diversify its investment portfolio and expand its existing healthcare-related investments.
This move is expected to reinforce Jungle Ventures’ foothold in the healthcare sector across Southeast Asia and India.
The new partnership will help Jungle Ventures’ vision of furthering its impact and influence within the healthcare landscape. Seemant Jauhari, an accomplished leader with 22 years of experience in healthcare investments and the driving force behind HealthXCapital since its inception, will transition to Jungle Ventures as a Partner dedicated to healthcare initiatives.
HealthXCapital, with its dedicated focus on the Southeast Asian and Indian healthcare landscape, has extensively engaged with over 1,200 founders representing diverse healthcare segments.
Their portfolio spans a wide spectrum of categories, encompassing home care, ambulatory care, insure-tech, data sciences, and brain health. Notable names within their portfolio include RED.Health, a healthcare technology company, and Homage, Medfin, and THB.
HealthXCapital is an early-stage investment platform that infuses smart and connected financial resources into burgeoning healthcare enterprises. With this strategic approach, the company plans to empower healthcare businesses in the thriving markets of Southeast Asia and India.
Backed by Apollo Hospitals, a prominent healthcare institution in India, and Jungle Ventures, a renowned venture capital firm with a presence in Singapore, HealthXCapital offers a unique model that furnishes startups it collaborates with a substantial competitive edge.
HealthXCapital’s maiden fund of $20 million, launched in 2018, has had Jungle Ventures as a limited partner. This fund has been instrumental in supporting and catalyzing the growth of healthcare startups targeting underserved Asian markets.
Jungle Ventures has carved out a niche by concentrating on nurturing startups from their inception to their evolution into unicorns and eventual IPOs. Founded in 2012, Jungle Ventures avoids the conventional approach of attempting to cater to a wide range of sectors. Instead, it focuses on strategic funding, targeting entrepreneurs with aspirations to lead on a national or global scale, thereby fostering the creation of category leaders.
Amit Anand and Anurag Srivastava established Jungle Ventures, securing $10 million for its inaugural fund in 2012. This momentum continued as they raised $100 million for their second fund in 2016, followed by a substantial $240 million for their third fund in 2019.
Jungle Ventures now directs its attention towards its fourth fund, which amassed an impressive $600 million—surpassing its initial target corpus of $350 million. The final close of the fourth fund took place in May of the previous year.
Within its extensive portfolio, Jungle Ventures helps startups like Moglix, Livspace, Builder.ai, and Atomberg. With a corpus of $600 million, the fund has already invested in a portion of its portfolio.
Read more from AsiaTechDaily